Arix Bioscience PLC: Clinical Development Update from Portfolio Company LogicBio

DJ Clinical Development Update from Portfolio Company LogicBio Arix Bioscience PLC (ARIX) Clinical Development Update from Portfolio Company LogicBio 09-May-2022 / 15:28 GMT/BST Dissemination of

Related Keywords

London ,City Of ,United Kingdom ,Ibrahim Khalil ,Sarah Macleod ,Frederic Chereau ,Arix Bioscience ,Prnewswire Logicbio ,Logicbio Press ,Drug Administration ,Logicbio Therapeutics Inc ,Nasdaq ,Powerscourt Group ,Dj Clinical Development ,Therapeutics Inc ,Portfolio Company Logicbio ,European Medicines Agency ,News Service ,Clinical Development ,Development Update ,Clinical Development Update ,Regulatory Announcement ,Logicbio Therapeutics ,New Drug Application ,Clinical Hold ,Pediatric Patients ,Methylmalonic Acidemia ,Member State ,Dow Jones Newswires ,Varix ,Ioscience ,Linical ,Development ,Update ,Rom ,Portfolio ,Company ,Logicbio ,